Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-11-18 Sale |
2024-11-20 5:00 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
12,099 | $0.1969 | $2,382 | 0 (Direct) |
View |
2024-04-03 Sale |
2024-04-05 4:30 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
10,451 | $4.95 | $51,732 | 0 (Direct) |
View |
2024-04-02 Sale |
2024-04-02 4:58 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
150 | $4.9803 | $747 | 41,118 (Direct) |
View |
2023-12-12 Sale |
2023-12-14 4:24 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,287 | $4.95 | $31,121 | 0 (Direct) |
View |
2023-12-06 Sale |
2023-12-08 4:23 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,287 | $3.95 | $24,834 | 6,287 (Direct) |
View |
2023-07-31 Sale |
2023-08-02 4:21 pm |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
7,348 | $3.95 | $29,025 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-10-31 Tax Withholding |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,776 | $2.09 | 12,099 (Direct) |
View |
2024-10-31 Exercise |
2024-11-04 5:01 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
18,875 | $0 | 12,099 (Direct) |
View |
2024-04-01 Tax Withholding |
2024-04-02 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
4,732 | $5.12 | 41,118 (Direct) |
View |
2024-03-31 Exercise |
2024-04-02 4:58 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
15,333 | $0 | 41,118 (Direct) |
View |
2023-11-01 Tax Withholding |
2023-11-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
6,301 | $2.22 | 31,449 (Direct) |
View |
2023-10-31 Exercise |
2023-11-02 4:52 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
18,875 | $0 | 31,449 (Direct) |
View |
2023-04-03 Tax Withholding |
2023-04-04 6:56 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
623 | $2.58 | 13,348 (Direct) |
View |
2023-03-31 Exercise |
2023-04-04 6:56 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
2,000 | $0 | 13,348 (Direct) |
View |
2023-02-16 Option Award |
2023-02-21 4:24 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
2022-10-06 Option Award |
2022-10-11 4:38 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
87,500 | $0 | 87,500 (Direct) |
View |
Ownership |
2022-07-11 5:15 pm |
N/A 2027-07-07 |
Allarity Therapeutics Inc. | ALLR | Roth David Director |
0 | $0 | 23,000 (Direct) |
View |
2022-04-01 Tax Withholding |
2022-04-04 5:03 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
27,281 | $1.12 | 59,719 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 4:10 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
405,000 | $0 | 405,000 (Direct) |
View |
2021-02-17 Option Award |
2021-02-19 4:13 pm |
N/A 2031-02-16 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
119,000 | $0 | 119,000 (Direct) |
View |